C

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Associate Director of Medical Writing - Medical Writing

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeRedwood City, CA, USA$189.5k - $223k

About the Job

Requirements

  • Excellent writing skills and a good understanding of the drug development process and relevant regulatory guidelines.
  • Ability to write and edit complex material for accuracy, clarity, consistency, and effectiveness.
  • Successful track record working on complex clinical and regulatory writing projects across multiple therapeutic areas.
  • Excellent attention to detail, multitasking, prioritization, and flexibility.
  • Excellent communication skills and ability to interact in a cross-functional environment.
  • Understanding of the drug-development process, including research and development processes and objectives and required documents.
  • Familiarity with United States and European regulatory requirements and guidelines for documents, and general knowledge of electronic Common Technical Document (e-CTD) requirements for structure, format, and content.
  • Ability to critically analyze and synthesize complex scientific information from a range of scientific disciplines and clinical therapeutic areas.
  • Proficiency with Microsoft Office applications (Word, Outlook, Excel, and PowerPoint), Adobe Acrobat, electronic document management systems such as Veeva Vault, Box, and SharePoint, and templates such as StartingPoint.
  • Ability to work in a fast-paced small-company environment with minimal direction and adjust workload as priorities change.
  • Initiative and ability to manage multiple projects simultaneously with minimal supervision.
  • Required BA/BS degree in a scientific field.
  • Seven or more years of regulatory medical writing experience in the pharmaceutical industry or an organization serving it, including experience writing clinical study protocols, clinical study reports, investigator’s brochures, clinical sections of Investigational New Drug submissions, and New Drug Applications; understanding of the content of higher-level summary documents.

Responsibilities

  • Author, co-author, critically edit, and format clinical and regulatory documents, including New Drug Applications, protocols and protocol amendments, clinical study reports, Investigator’s Brochures, and other regulatory submissions as needed.
  • Interact with document authors, contributors, and reviewers, including Biometrics, Clinical Operations, Clinical Development, Project Management, CMC, Drug Safety, and Regulatory Affairs, to acquire necessary document input.
  • Develop and manage medical-writing timelines for assigned documents to ensure on-time deliverables that meet business needs.
  • Lead comment resolution and adjudication with authors, reviewers, and project teams.
  • Oversee vendors and contractors.
  • Management of in-house medical-writing staff may be included, based on experience and team need.
  • Serve as the functional-area representative on project teams and advise teams on document content, format, and style requirements.
  • Lead development and refinement of medical-writing processes, SOPs, work instructions, templates, style and content guides, and document quality control to ensure efficient preparation of high-quality deliverables.
  • Maintain subject-area expertise related to the company’s investigational products, disease indications, and regulatory and publication guidelines.

Desired Qualifications

  • An advanced scientific degree (PhD, PharmD, or MS) is preferred.

About the Company

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Corcept Therapeutics develops and commercializes cortisol modulators to treat disorders caused by abnormal cortisol levels. Its core product, Korlym (mifepristone), blocks cortisol’s action by acting as a cortisol receptor antagonist and is approved for hypercortisolism in Cushing’s syndrome. The company differentiates itself with a dedicated focus on cortisol modulation, an extensive pipeline of proprietary molecules, and ongoing development beyond Korlym. Its goal is to improve outcomes for patients with cortisol-related disorders by expanding access to effective therapies and advancing new treatments.

Company size
501-1,000
Company stage
IPO
Headquarters
Menlo Park, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Corcept Therapeutics

See more jobs